ConMed Foresees Dramatic Virus-Related Declines in 2Q20
The company declined 12.5% in 1Q20 and believes the market low point will be in the second quarter. ConMed's orthopedic sales for April are projected to decline by 65%. May 01, 2020
We've found 292 results
Bone Therapeutics Secures EUR 11.0 Million Financing
Funds will support studies of ALLOB allogeneic cell therapy to treat difficult tibial fractures and JTA-004 protein to treat for osteoarthritic knee pain. Apr 29, 2020
Trice Medical Launches Fully Disposable Endoscopic Carpal Tunnel System
Seg-WAY ECTR-d features all instruments needed to complete an endoscopic carpal tunnel release and can be used with the disposable mi-eye angled camera. Apr 28, 2020
ATEC Terminates Agreement to Acquire EOS imaging
ATEC terminated the agreement to acquire EOS imaging after determining the transaction not feasible due to the negative market impacts of COVID-19. Apr 27, 2020
COVID-19 Amplifies Focus on the Cost of Care
In this video, trauma surgeon Peter Althausen, M.D., says COVID-19 will shift procedures to outpatient settings and place scrutiny on implant utilization. Apr 27, 2020
COVID-19 is a Disruption Accelerator. Are You Prepared?
Tiger Buford talks about changes to technology and the roles of product development and sales and marketing post-COVID-19. Apr 23, 2020
aap Gains Approval for Study of Silver Coating Technology
aap's antibacterial silver coating technology has applications in trauma devices and other areas inside and outside of orthopedics. Apr 23, 2020
Conformis, Medtronic Provide Status Updates on COVID-19 Impact
The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to share how competitors and customers are reacting. Apr 23, 2020
Retiring Bioventus CEO Shares Thoughts on Orthobiologics Market
Mr. Bihl feels that orthobiologics are in a unique position to address unmet needs that remain prevalent despite advancements in traditional orthopedic products. Apr 22, 2020
DePuy Synthes Down 7.5%, Bracing For More Extreme Declines
DePuy Synthes declined 7.5% in 1Q20 due to the impact of the COVID-19 pandemic, with the worst expected to come in 2Q as procedures are deferred en masse. Apr 16, 2020
